SCHEMBL7295337

SCHEMBL7295337

Cc1nc(-c2ccc(OCc3ccccc3)cc2)no1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.59
NPC1 O15118 3/20 0.59
CASP3 P42574 1/20 0.59
SENP8 Q96LD8 1/20 0.59
SENP7 Q9BQF6 1/20 0.59
SENP6 Q9GZR1 1/20 0.59
ENPP3 O14638 1/20 0.58
ENPP1 P22413 1/20 0.58
L3MBTL1 Q9Y468 3/20 0.55
MAPK1 P28482 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
PPARD Q03181 5/20 0.55
PPARA Q07869 5/20 0.55
SMPD1 P17405 2/20 0.54
TSHR P16473 2/20 0.52
AOC3 Q16853 2/20 0.52
MAPT P10636 1/20 0.51
LMNA P02545 1/20 0.49
NFKB1 P19838 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3506676 0.87 RAB9A (0.53) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL7297949 0.86 RAB9A (0.50) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL3505981 0.85 RAB9A (0.53) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL17707864 0.85 NR1H4 (0.61) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL7295341 0.85 SPHK2 (0.59) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL3505092 0.85 L3MBTL1 (0.55) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL3504096 0.84 DHFR (0.62) L3MBTL1MAPK1TDP1SMPD1TSHR
SCHEMBL3061817 0.84 NR1H4 (0.64) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL3504473 0.83 ACACB (0.65) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL3056578 0.82 NR1H4 (0.74) RAB9ANPC1L3MBTL1TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0504574-B1 1,2,4-Oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity and method for preparing same WAKAMOTO PHARMA CO LTD (JP) 1996-02-28 EP claimed
EP-0504574-B1 1,2,4-Oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity and method for preparing same WAKAMOTO PHARMA CO LTD (JP) 1996-02-28 EP disclosed
US-5356916-A Treating Parkinson*s disease WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1994-10-18 US disclosed
EP-0504574-A1 1,2,4-Oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity and method for preparing same Wakamoto Pharmaceutical Co., Ltd. (JP) 1992-09-23 EP disclosed